£515.00

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

Uterine Cancer Therapeutics and Diagnostics in India Outlook

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 87 days · 87 data points (no recent data)

Historical
Generating forecast…
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 11 August 2026 01 September 2026 23 September 2026 14 October 2026 05 November 2026
View at Amazon ↗

Price data checked 4 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 87 days • 1 price levels

Days at Price
87 days 0 22 44 65 87 £515 Days at Price

Price Analysis

Most common price: £515 (87 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 87 days

Description

This comprehensive study provides a detailed outlook for the uterine cancer therapeutics and diagnostics market in India from 2023 to 2028. It focuses on latent demand estimates, also known as potential industry earnings (P.I.E.), measured in millions of U.S. dollars. The data covers a massive scale, providing insights across states, union territories, and over 4,900 cities throughout India. By offering percent share comparisons for each city relative to its state, union territory, and the national total, this report serves as a vital tool for market analysis. These comparative benchmarks help professionals quickly evaluate different locations, making the statistical approach highly effective for developing precise distribution and sales force strategies within the Indian healthcare sector.

Key Features

Provides latent demand outlooks for uterine cancer therapeutics and diagnostics in India for the 2023-2028 period.

Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for over 4,900 cities.

Delivers comparative benchmarks by reporting the percent share of each city relative to its state and union territory.

Offers national market context by calculating each city's share of the total Indian market.

Supports strategic planning for distribution and sales force management through detailed geographic data.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
29 September 2022

Similar Products You Might Like

Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028
99% match

Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028

£520.00 06 Nov 2026
The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics
99% match

The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics

£795.00 25 Aug 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
99% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China

£495.00 17 Sep 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan
99% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan

£495.00 25 Aug 2026
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics
98% match

The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics

Price unavailable
Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028
98% match

Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028

£490.00 06 Nov 2026
World Outlook: Uterine Cancer Treatments and Diagnostics
98% match

World Outlook: Uterine Cancer Treatments and Diagnostics

Price unavailable
US Cancer Supportive Care Outlook 2023-2028 Study Report
98% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
India Cancer Supportive Care Drugs Outlook 2023-2028
98% match

India Cancer Supportive Care Drugs Outlook 2023-2028

£515.00 06 Nov 2026
Cancer Supportive Care Drugs Outlook 2023-2028 Report
98% match

Cancer Supportive Care Drugs Outlook 2023-2028 Report

£520.00 06 Nov 2026
2023-2028 US Cancer Screening Outlook - Market Study
98% match

2023-2028 US Cancer Screening Outlook - Market Study

£520.00 05 Nov 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
The 2023-2028 Outlook for Gynecologic Oncology in the United States
98% match

The 2023-2028 Outlook for Gynecologic Oncology in the United States

£520.00 28 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India
97% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India

£515.00 03 Oct 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
97% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£520.00 06 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States
97% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States

£520.00 02 Oct 2026
Cervical Cancer Treatment Outlook in India 2023-2028
97% match

Cervical Cancer Treatment Outlook in India 2023-2028

£515.00 08 Nov 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
Bladder Cancer Therapeutics Outlook Japan 2016-2021
97% match

Bladder Cancer Therapeutics Outlook Japan 2016-2021

£595.00 28 Aug 2026
Cervical Cancer Treatment Outlook 2023-2028 - US Market
97% match

Cervical Cancer Treatment Outlook 2023-2028 - US Market

£520.00 25 Aug 2026
Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028
97% match

Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028

£515.00 07 Nov 2026